Volatile organic compound impacts on immune functions during pregnancy: molecular mechanisms for potential interventions

Active Project Grant Awarded Last action

Award ID
R01ES038132
Recipient
Awarding agency
Obligated
$795,869

Award facts

Assistance listing
93.113 Environmental Health
Completion date 12% complete
Place of performance
Ann Arbor, MI 48109, USA

Award details come from USAspending.gov.

About this award

The National Institute of Environmental Health Sciences awarded $795,869 to Regents of the University of Michigan on April 16, 2026, under the Environmental Health program (CFDA 93.113) to investigate volatile organic compound impacts on immune functions during pregnancy and identify molecular mechanisms for potential interventions.

The research examines how environmental toxicants, specifically trichloroethylene (TCE) and perchloroethylene (PCE), disrupt immune defenses in the uterus, fetal membranes, and placenta during pregnancy. The work focuses on understanding how volatile organic chemical exposure increases susceptibility to intrauterine infections such as group B streptococcus, which is associated with preterm birth, stillbirth, and neonatal sepsis. Preliminary data show that a TCE metabolite blocks immune responses to bacterial infection in fetal membrane explants and suppresses macrophage immune responses via downregulation of transcriptional immune pathways and cytokine release. The research aims to translate these mechanistic findings into strategies to reduce adverse pregnancy outcomes caused by environmental exposures.

Work is performed in Ann Arbor, Michigan, with performance through February 28, 2031. The University of Michigan Office of Research and Sponsored Projects administers the award.

Two sub-recipients participate in the project. Indiana University's Trustees, through Dr. David Aronoff at Indiana University School of Medicine, collects placental tissue and conducts macrophage function experiments using a primary decidual macrophage model (sub-award awarded June 8, 2026). Calvin University, through Dr. Erica Boldenow in the Department of Biology, provides expertise in pregnant rodent models, immunohistochemical analysis, and primary immune isolations and cell culture, and assists with animal experiments and data analysis (sub-award awarded May 29, 2026).

Description

Abstract
Immune functions in the uterus, fetal membranes and placenta are critical to maintaining a healthy pregnancy. These tissues perform a delicate balancing act by maintaining antimicrobial immune defenses while promoting maternal immune tolerance of the fetus. Mounting evidence suggests that environmental toxicants can disrupt key functions of the immune system. However, critical gaps remain in our understanding of how environmental toxicants affect immune functions in gestational tissues. Filling these gaps is necessary to effectively design interventions aimed at preventing adverse pregnancy health outcomes caused by environmental exposures. Volatile organic chemicals (VOCS) like trichloroethylene (TCE) and perchloroethylene (PCE) are widespread immunotoxic environmental contaminants. VOC exposure has been shown to disrupt multiple immune processes, including host defenses against pathogenic bacteria. This has important implications for pregnancy health, as the public health burden of intrauterine infections during pregnancy is high. For example, intrauterine infections with bacteria like group B streptococcus (GBS) is associated with outcomes like preterm birth, stillbirth and neonatal sepsis. Studies have identified associations between VOC exposure and immune system dysfunctions, increased risk for certain infections, as well as adverse pregnancy outcomes at least partially mediated by immune cells, like fetal growth restriction. However, TCE and PCE impacts on immune functions during pregnancy are not well understood. Our preliminary data show that a TCE metabolite, S-(1,2- dichlorovinyl)-L-cysteine (DCVC), blocks immune responses to GBS in fetal membrane explants and suppresses macrophage immune responses to bacterial toxins via downregulation of transcriptional immune pathways and cytokine release. Moreover, we showed that both DCVC and the PCE metabolite S-(1,2,2- trichlorovinyl)-L-cysteine downregulate antimicrobial and immune tolerance pathways in human placental explants EX vivo. These findings suggest that VOC metabolites exert immunosuppressive effects in gestational tissues. We now seek to define the immunotoxic effects of TCE and PCE metabolites across gestational cell types and tissues. In addition, we propose to identify molecular mechanisms underpinning these effects. In this project we will: (1) assess TCE and PCE metabolite impacts on antimicrobial functions in primary uterine decidual macrophages (a key cell type in maintaining immune defenses against intrauterine infections), (2) identify TCE and PCE metabolite impacts on microbial host defense responses to GBS in human fetal membrane explants, (3) identify transcriptomic impacts on specific immune cell types in the placentas of TCE or PCE treated pregnant rats (with or without GBS infection) and (4) determine the extent to which TCE or PCE exposure leads to increased GBS colonization of the uterus, fetal membranes and placenta in a RAT model. Using TCE/PCE and GBS as model toxicant-pathogen interactions, this project will provide important insights into how environmental toxicants affect immune functions during pregnancy.

Subawards

Subrecipient Amount Awarded
Trustees Of Indiana University Dr. David Aronoff, Professor and Chair, Department of Medicine, Indiana University School of Medicine, will serve as Co-Investigator on this research project… $100,725
Calvin University Dr. Erica Boldenow, Associate Professor in the Department of Biology and Public Health Program, will serve as Co- Investigator on this research project with the… $60,861

Quick answers

Who received award R01ES038132?

R01ES038132 was awarded to Regents Of The University Of Michigan by National Institute of Environmental Health Sciences (National Institutes of Health) on April 16, 2026.

How much is award R01ES038132 worth?

$795,869 has been obligated on R01ES038132.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award